ES2540747T3 - Combinación antiinflamatoria tópica - Google Patents

Combinación antiinflamatoria tópica Download PDF

Info

Publication number
ES2540747T3
ES2540747T3 ES09800811.3T ES09800811T ES2540747T3 ES 2540747 T3 ES2540747 T3 ES 2540747T3 ES 09800811 T ES09800811 T ES 09800811T ES 2540747 T3 ES2540747 T3 ES 2540747T3
Authority
ES
Spain
Prior art keywords
composition
topical anti
effective amount
inflammatory combination
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09800811.3T
Other languages
English (en)
Inventor
William Zev Levine
Aron Jay Saffer
Gabriel Nussbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Izun Pharmaceuticals Corp
Original Assignee
Izun Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Izun Pharmaceuticals Corp filed Critical Izun Pharmaceuticals Corp
Application granted granted Critical
Publication of ES2540747T3 publication Critical patent/ES2540747T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Una composición para su uso en el tratamiento o la mejora del acné que comprende la aplicación periódica a un tejido afectado por tal enfermedad de la composición que comprende una cantidad eficaz de una composición apropiada de principios bioactivos de hierbas que comprenden principios activos de una o más de Sambucus nigra, Centella asiatica o Echinacea purpurea, y una cantidad eficaz de un tensioactivo de amonio cuaternario.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6

Claims (1)

  1. imagen1
ES09800811.3T 2008-07-22 2009-07-15 Combinación antiinflamatoria tópica Active ES2540747T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8261308P 2008-07-22 2008-07-22
US82613P 2008-07-22
PCT/US2009/050661 WO2010011541A2 (en) 2008-07-22 2009-07-15 Topical anti-inflammatory combination

Publications (1)

Publication Number Publication Date
ES2540747T3 true ES2540747T3 (es) 2015-07-13

Family

ID=41570811

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09800811.3T Active ES2540747T3 (es) 2008-07-22 2009-07-15 Combinación antiinflamatoria tópica
ES15164503.3T Active ES2688025T3 (es) 2008-07-22 2009-07-15 Combinación antiinflamatoria tópica

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES15164503.3T Active ES2688025T3 (es) 2008-07-22 2009-07-15 Combinación antiinflamatoria tópica

Country Status (9)

Country Link
US (2) US8771759B2 (es)
EP (2) EP2320920B1 (es)
JP (1) JP5707655B2 (es)
KR (2) KR101763334B1 (es)
CA (2) CA2731445C (es)
EA (1) EA201170239A1 (es)
ES (2) ES2540747T3 (es)
IL (2) IL210820A0 (es)
WO (1) WO2010011541A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN104394875B (zh) * 2012-03-14 2018-12-04 Izun制药公司 用于治疗疾病的新颖的方法和组合物
WO2014159238A1 (en) 2013-03-14 2014-10-02 Mary Kay Inc. Cosmetic compositions
CN108379546A (zh) * 2018-05-29 2018-08-10 广州聚澜健康产业研究院有限公司 一种私处洗液及其制备方法
JP2020130771A (ja) * 2019-02-22 2020-08-31 キヤノン株式会社 加工装置、加工方法及びプログラム
WO2020209702A1 (ko) * 2019-04-12 2020-10-15 이연제약 주식회사 자주천인국 착즙액을 포함하는 피부질환 개선, 치료 또는 예방용 조성물
ES2965159T3 (es) 2019-07-29 2024-04-11 Echo Pharmaceuticals Bv Tratamiento de trastornos de glándula sebácea
CA3149121A1 (en) 2019-07-29 2021-02-04 Echo Pharmaceuticals B.V. Treatment of inflammatory skin conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945061A (en) * 1960-04-21 1963-12-18 Vantorex Ltd Improvements in or relating to dermatological compositions
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
JPH11322623A (ja) * 1998-12-24 1999-11-24 Meril Skyers ヘルペスシンプレックスウイルスおよび他の感染病のための抗菌治療
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6355229B1 (en) * 2001-06-27 2002-03-12 Church & Dwight Co., Inc. Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same
JP4092267B2 (ja) * 2003-07-14 2008-05-28 ポーラ化成工業株式会社 生薬抽出物を含有する皮膚外用剤
KR20060108665A (ko) * 2003-10-10 2006-10-18 액세스 비지니스 그룹 인터내셔날 엘엘씨 로즈마리누스 오피시날리스 식물 추출물, 센텔라,에치나세아 또는 알피니아 식물 추출물 및 ｄｎａ 복구효소를 포함하는 조성물
DE20320103U1 (de) * 2003-12-23 2004-07-15 Weber & Weber Gmbh & Co. Kg Pharmazeutische Zubereitung zur topischen Behandlung von Hauterkrankungen
US7727119B2 (en) 2004-09-27 2010-06-01 Therapease Innovation, Llc Human self-powered joint exerciser apparatus
ES2747729T3 (es) 2004-11-22 2020-03-11 Izun Pharmaceuticals Corp Dispositivo de administración oral a través de la mucosa
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
JP5513111B2 (ja) * 2006-07-20 2014-06-04 イズン ファーマシューティカルズ コーポレイション フィルム送達リンス

Also Published As

Publication number Publication date
EP2937093B1 (en) 2018-07-04
CA3000497A1 (en) 2010-01-28
JP2011529055A (ja) 2011-12-01
WO2010011541A3 (en) 2010-04-29
KR20160120758A (ko) 2016-10-18
US8771759B2 (en) 2014-07-08
WO2010011541A2 (en) 2010-01-28
US20140099389A1 (en) 2014-04-10
ES2688025T3 (es) 2018-10-30
KR20110063434A (ko) 2011-06-10
US20110151032A1 (en) 2011-06-23
EP2320920A2 (en) 2011-05-18
KR101763334B1 (ko) 2017-07-31
CA3000497C (en) 2019-09-10
CA2731445A1 (en) 2010-01-28
IL243546A (en) 2017-11-30
IL210820A0 (en) 2011-04-28
EP2320920B1 (en) 2015-04-22
CA2731445C (en) 2018-05-15
EP2320920A4 (en) 2012-10-24
JP5707655B2 (ja) 2015-04-30
EP2937093A1 (en) 2015-10-28
US9314491B2 (en) 2016-04-19
KR101660246B1 (ko) 2016-09-27
EA201170239A1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
ES2540747T3 (es) Combinación antiinflamatoria tópica
ES2602986T3 (es) Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
ES2545975T3 (es) Composición que contiene piceatannol y procedimiento para producir la composición que contiene piceatannol
CL2007003245A1 (es) Composicion farmaceutica en capa que comprende dos o mas capas farmaceuticas y al menos una capa intermedia dispuesta entre al menos dos o mas capas, donde la capa intermedia es configurada para disolverse in vivo donde dichas dos capas farmaceuticas
ECSP088490A (es) Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
CL2012002031A1 (es) Composición farmacéutica que contiene al menos un compuesto fgf-21 (factor de crecimiento de fibroblastos 21) y al menos un agonista del glp-1r (receptor del péptido 1 similar al glucagón); y su uso para preparara un medicamento para el tratamiento de al menos un síndrome metabólico y/o aterosclerosis en un paciente.
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BRPI0911273A2 (pt) inibidor de dpp-iv combinado com outro agente antidiabético, comprimidos que compreendem tais formulações, seu uso e processo para sua preparação
ES2478264T3 (es) Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
CL2008002984A1 (es) Composicion farmaceutica que comprende micofenolato sodico y su uso para el tratamiento y/o prevencion en enfermedades autoinmunes tales como el rechazo de aloinjertos o xenoinjertos de organos, celulas o tejidos y como antiinflamatorio.
CL2008002999A1 (es) Uso de una composicion farmeceutica que comprende trns-clominefo para preparar un medicamenteo util en el ratamiento de recuccion de los niveles de glucosa en ayunas en un varon.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CL2008002758A1 (es) Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento.
ES2582309T3 (es) Uso de trinitrato de glicerilo para el tratamiento de edema traumático
GT200900296A (es) Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante.
ES2555055T3 (es) Uso de una asociación sinérgica de iones hipotiocianato y/o hipohalito y de lactoferrina para la preparación para el tratamiento de la fibrosis quística
CL2011000388A1 (es) Combinacion farmaceutica que comprende (6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y un antiinflamatorio no esteroidal; forma de dosificacion; uso en el tratamiento de la osteoartritis y el dolor.
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
ES2577405T3 (es) Composiciones para el tratamiento de úlceras periféricas de varios orígenes